Image courtesy of Aditya Oberai.

Climate change expands tick ranges, so disease risks increase for everyone. Ticks spread several spotted fevers like Rocky Mountain spotted fever and rickettsial pox. These diseases all come from bacteria within the rickettsia genus. Rising tick movement now raises new concerns for animal and human health.

A new spotted fever organism recently killed multiple dogs in the United States. Researchers are watching this bacterium closely to prevent possible human transmission. Many rickettsia relatives can infect humans with serious disease. Experts say they should always be treated as potentially harmful.

North Carolina State University scientists cultured this new rickettsia bacterium from a sick dog. The dog showed symptoms similar to Rocky Mountain spotted fever infections. Sequencing revealed an entirely new species within the rickettsia lineage. Researchers named it Rickettsia finnyi after Finny, the infected dog.

An author of the study, Barbara Corollo, said this species first appeared in 2020. That early cluster involved three dogs with similar severe symptoms. She said 16 more dog samples have since tested positive. Most infections occurred across southeastern and midwestern states.

How Dangerous is the New Bacterium?

These infections produce symptoms that vary widely in severity. Common signs include fever, lethargy, and reduced blood platelet counts. Antibiotics helped many dogs recover after quick treatment. However, one dog died before diagnosis and another was euthanized.

Another pet improved briefly, but later relapsed with nephrotic syndrome. This kidney disorder causes protein loss in urine and severe body swelling. It also leads to low blood protein and dangerous cholesterol changes. The condition eventually caused the dog’s death after its relapse.

Rocky Mountain spotted fever remains one of the most dangerous rickettsia species. Yet more than two dozen relatives can also infect mammals today. Many of these species were discovered only through advanced modern imaging tools. Their detection shows how complex tick-borne threats continue to grow.

Humans and dogs are not required hosts for rickettsia development. However, these bacteria can still use them as temporary carriers. This means infections can spread even without essential host dependence. These trends highlight the growing urgency of monitoring tick-borne threats.

How Does the Bacterium Spread?

Human habitats often overlap natural tick habitats across many regions today. Each overlap increases the chance of ticks spreading to new hosts. This overlap raises risks for both household pets and people. It also expands the environments where emerging pathogens may appear.

Only a few dogs currently have confirmed cases of this bacterium. However, more diagnoses may follow as awareness and testing improve. The bacterium can survive inside mammal cells for long periods. This study suggests it may continue growing for more than 104 days.

Pets can therefore act as strong reservoirs for this infection. Long-lasting infections increase the chance of exposure through tick bites. These patterns make household animals important indicators of local disease spread. They also help researchers track how new pathogens circulate.

Scientists believe the lone star tick is the most likely vector. Oklahoma researchers found R. finnyi DNA inside lone star tick samples. Regions with abundant lone star ticks match areas where dogs became sick. These findings strengthen the link between this tick and the new disease.

More research is needed to confirm the exact host and vector. Pinpointing the host will help experts design better prevention steps. It will also guide monitoring programs in high-risk regions. These efforts may prevent larger outbreaks in pets and their communities.

Conclusion

This new infectious bacterium in dogs shows how fast tick threats evolve. The bacterium has already sickened dogs and may spread through lone star ticks. Continued research will help experts track its movement and protect communities.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of PIRO4D.

The fall of Constantinople bears similarity to a surprising microscopic discovery. In some accounts, the Ottoman conquest succeeded when one gate was left open. That small mistake allowed invaders to enter the once-impregnable city. Some historians note the conquest may have hinged on that doorway.

Scientists see a similar pattern in recent flu research. High-resolution imaging shows flu viruses entering human cells in real time. These images reveal cells do not passively wait for infection. Instead, they sometimes help guide the virus inside.

Researchers from Switzerland and Japan built a bespoke microscopy system. Their tool zooms closely on the cell’s outer membrane in a dish. This system helps scientists watch flu viruses penetrate living cells. The work captures infection processes at extremely high resolution.

The results surprised the research team studying cell behavior. Cells did not remain dormant when the virus approached them. Instead, each cell seemed to reach out and actively grab the virus. Lead researcher Yohei Yamauchi described this moment as a “dance” between virus and cell.

How Do Cells Help Viruses Enter?

Cells gain nothing from letting viruses enter them. However, cells still participate because of a normal intake system. The flu virus exploits this system to make the cell consume it. This process usually helps cells absorb hormones, cholesterol, and iron.

This behavior is like someone forced to eat poisoned food. The ingestion method itself works normally and remains well-designed. The cell simply cannot detect unsafe material in time. That confusion allows the flu virus to enter without resistance.

Flu viruses attach to targeted molecules sitting on the cell surface. This step lets the virus glide across the membrane while searching. It continues latching onto molecules until it finds dense receptor sites. These sites create the best entry points for viruses seeking access.

How Did Scientists See This Process?

This process had never been recorded in such detail before. Electron microscopy requires destroying cells to capture their structure. That method only shows one moment, rather than the entire sequence. Fluorescence microscopy offers live views but with limited resolution.

The new method solves these problems by combining two tools. It uses atomic force microscopy together with fluorescence microscopy. Researchers call the hybrid tool virus-view dual confocal and AFM (ViViD-AFM). This technique captures subtle movements showing how viruses enter cells.

The tool revealed several distinct stages of viral entry. Clathrin proteins gather at the spot where the virus attaches. Then the cell membrane rises upward as if trying to grab it. These motions resemble gentle waves that strengthen when viruses shift away.

ViViD-AFM makes live detailed observation possible in cell cultures. It could help researchers test antiviral drugs with real-time monitoring. Scientists may study more viruses and design improved vaccines. These insights could support future breakthroughs in antiviral research.

Conclusion

This recent study shows how cells actively help flu viruses enter them. The new microscopy method reveals detailed movements that guide viral entry. These insights could strengthen antiviral research and support future vaccine development.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Nop Viwat.

Common vaccines may help protect the aging brain. Recent studies found that shingles and RSV vaccines could lower dementia risk. A new study offers even stronger evidence supporting shingles vaccine dementia protection. These findings suggest that vaccines may offer a promising path for preventing the disease.

What Makes the Recent Findings Significant?

Research in NPJ Vaccines examined Shingrix and Arexvy, two vaccines that protect against shingles and RSV. The study found that both vaccines may also help reduce dementia risk. The researchers traced these protective effects to an immune-boosting adjuvant called AS01.

The study reported strong benefits for vaccinated people. Those who received the shingles vaccine showed an 18% lower dementia risk. The researchers believe AS01 plays a key role in strengthening immune memory. This connection may help protect the brain during aging.

However, the researchers noted major study limitations. People who choose vaccines are often healthier overall than those who decline. They may eat better diets and engage in more physical activity. These lifestyle factors strongly influence dementia risk, but rarely show up in medical records.

These hidden factors can create important confounding variables. They can make vaccines appear more protective than they actually are. Researchers needed a way to separate vaccine effects from everyday habits. That required a study design closer to a randomized controlled trial.

What Does the New Study Reveal?

A new Stanford Medicine study created that opportunity. A vaccination program in Wales offered the shingles vaccine only to seventy-nine-year-olds. People aged eighty or older were not eligible for the program. This policy difference allowed researchers to compare groups divided by rules, not lifestyle.

This design removed many hidden confounding variables. The groups differed because of government policy rather than personal habits. That separation allowed researchers to observe the vaccine’s true impact. The results revealed a powerful protective effect against dementia.

The vaccine still reduced dementia risk in this controlled setting. With lifestyle factors removed, the shingles vaccine lowered dementia risk by twenty percent. This reduction persisted through the next seven years of follow-up. Researchers say these findings strengthen the evidence for real protective benefits.

Some viruses attack the nervous system and may raise long-term dementia risk. More research confirming this link could change future prevention strategies. It may even reveal that we already have a useful preventative tool in vaccines.

Researchers designed a companion study to test this idea further. The study appeared in Cell and explored vaccine effects on diagnosed dementia. The researchers found that the vaccine may help people already showing symptoms. Their data suggest it could slow the progression of dementia over time.

What to Know about Shingles and Dementia

Shingles is caused by a virus that produces a painful rash. The virus behind shingles is the same virus that causes chickenpox. This virus is called varicella-zoster and is common in childhood. After infection, it remains inside nerve cells for a person’s entire life.

The virus can reactivate as people age. Immune systems weaken over time and allow varicella zoster to awaken. When this happens, the virus causes shingles in older adults. This makes shingles a major health concern for aging populations worldwide.

Dementia also affects large populations around the world. More than five hundred fifty million people live with dementia today. Around ten million new diagnoses appear every single year. Alzheimer’s disease is the most prevalent type and remains difficult to treat.

Research has long focused on plaques and tangles in the brain. These structures can disrupt memory and alter brain function over decades. However, limited progress has pushed scientists to explore new possibilities. That search now includes studying how vaccines may help protect the brain.

Conclusion

These findings show strong links between shingles vaccination and dementia protection. The vaccine may lower dementia risk, slow disease progression, and improve survival. Researchers now hope that a large randomized trial will confirm these powerful effects.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Ec lipse.

A Washington State resident has died from H5N5 bird flu. This case marks the world’s first death from this rare strain and the first recorded human infection. Officials say the event highlights a new chapter in global bird flu surveillance.

The patient was older and had underlying health conditions. They had been hospitalized for an extended period before death, and state officials provided no further identifying details. Investigators are still reviewing the patient’s medical and exposure history.

The CDC confirmed the H5N5 infection and continues to classify the public risk as low. Officials say that no additional people have tested positive for bird flu. They also report no evidence of human-to-human transmission at this time.

Investigators say the patient was exposed by a backyard flock with mixed domestic bird species. Exposure to infected birds remains the most common source of transmission. Officials are monitoring nearby flocks to ensure no further spread occurs.

What Bird Flu Trends Relate to This Death?

The United States has now recorded two bird flu deaths in the last year. The previous death involved H5N1 in a Louisiana resident. More than 70 human bird flu cases have been confirmed nationwide since last year.

The WHO has documented over 1,000 global bird flu cases since 2023 across 25 countries. This figure includes all circulating bird flu strains now affecting humans. Officials say continued outbreaks highlight long-term risks that require close monitoring.

Officials say samples pinpointed Berkeley virus in the patient’s backyard flock. This discovery confirms that he was most likely exposed there. Others also had contact with the flock, so officials are monitoring them.

Bird flu is caused by influenza type A viruses. These viruses circulate naturally in wild aquatic birds worldwide. Bird flu can spill into other bird species and sometimes mammals. Outbreaks can kill large numbers of domestic birds like chickens and turkeys.

How to Stay Safe from Bird Flu

Human infections are rare, but some cases can be fatal. The Washington Department of Health shared several guidelines to prevent infection. They say these steps can reduce risk for people with backyard birds.

People with backyard poultry should avoid sick or dead birds. Report any poultry illness to proper authorities quickly. Vets must also report any sick or dead domestic animals that might have bird flu. People should avoid touching sick or dead wildlife, especially wild birds.

Keep pets away from dead birds and other sick wildlife. Avoid raw or undercooked foods, including raw cheese and unpasteurized milk. These items should also be kept away from pets.

People exposed to domestic or wild birds should receive a seasonal flu vaccine. This vaccine does not block bird flu infection directly. It instead prevents someone from being sick with both viruses simultaneously. Dual infection could allow a bird flu virus to evolve person-to-person spread.

Health officials recommend seasonal flu vaccines for everyone six months or older. They say widespread vaccination reduces overall flu risk. It also helps protect communities during large bird flu outbreaks.

Conclusion

Health officials say this death highlights rising concerns about evolving bird flu strains. They stress that human risk remains low but requires continued monitoring. Officials also urge people to follow safety guidance to reduce future infections.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of cottonbro studio.

Recent research shows that preventing RSV in newborns can prevent asthma. RSV infection early in life can raise long-term asthma risk. The effect is strongest in children with genetic allergy risks. Early RSV infections also push the immune system to overreact to allergens.

Newborns who receive preventative RSV medication develop asthma less often. These findings show another benefit of early RSV protection. They also highlight the importance of inoculating young children. Protecting newborns may reduce severe asthma across communities.

Researchers from Belgium and Denmark conducted this large study together. Teams from V.I.P. and Ghent University collaborated with Danish scientists. They published their results in Science Immunology. Their work addresses a major health burden.

Asthma affects 5–15% of European children today. This long-term illness harms daily well-being and family life. It also creates heavy financial strain for health systems. These challenges have pushed experts to pursue new prevention strategies.

How Does RSV Protection Prevent Asthma?

The study compared Danish health registry data with controlled lab studies. This comparison revealed how early RSV infection raises genetic allergy risk. Infants with severe RSV in early months show increased allergen sensitivity. Common triggers include dust mites, often found in homes.

Inherited asthma and allergies intensify this link further. Antibodies passed from parents increase dangerous allergy responses. These inherited factors push infants toward stronger reactions. The combined risks make early RSV protection even more important.

Results showed that RSV inoculation can stop these immune changes entirely. Experimental models confirmed this protective effect. Preventing RSV in newborns prevented asthma development. These findings strengthen the case for early RSV protection.

The study included data from nearly 1.5 million children. The authors say this makes it the most comprehensive RSV–asthma study. They also note the scale strengthens confidence in their findings. The work establishes a clearer link between RSV and asthma risk.

The researchers also highlighted another important finding. Parental asthma history raises risk, but is not required. Even children without genetic history show increased asthma risk after RSV. This finding widens concern for all newborns.

What Next Steps Can Reduce Childhood Asthma?

Professor Hamida Hamad served as the study’s co-senior author. She said wide RSV prevention access can improve respiratory health. Hamad also said the research scope could extend beyond RSV. Her team hopes parents will choose RSV vaccination for newborns.

Many countries now use maternal RSV vaccination in late pregnancy. These vaccines are given during the third trimester. Nations also encourage newborn vaccination using long-lasting antibodies. These strategies aim to reduce RSV infections and later asthma risk.

The authors acknowledged one key limitation in their study. Asthma and RSV data only came from hospital diagnostics. This limitation means milder cases treated by GPs were excluded. The study could therefore underestimate RSV’s total impact on asthma.

The team recommends more research to explore early-life RSV prevention. They want to know if delaying RSV infections changes later illness. Preventative protocols could help stop other long-term respiratory diseases. These efforts may improve childhood health for years ahead.

Conclusion

Preventing RSV in newborns could reduce childhood asthma across entire populations. The study’s large dataset shows strong links between early RSV and asthma. These findings support broader use of RSV prevention to protect long-term respiratory health.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of CDC.

Vaccination has reduced measles deaths by 88% from 2000 to 2024. The World Health Organization (WHO) says almost 59 million lives were saved by the vaccine. Still, measles killed about 95,000 people in 2024. Most deaths occurred in children younger than five years old.

The 2024 statistic shows one of the lowest annual death totals since 2000. Yet every preventable death reflects a major global failure. This is especially tragic when a cheap and effective vaccine exists. Lower deaths also do not erase the reality of rising global measles cases.

Measles caused about 11 million infections in 2024. This number exceeds 2019 pre-pandemic records by almost 800,000 cases. The WHO’s Director-General, Dr. Tedros Adhanom Ghebreyesus, called measles the most contagious virus. He warned that any weakness in global defenses can be exploited quickly.

What Measles Trends Did the Report Find?

Global regions saw major rises in measles cases between 2019 and 2024. The Eastern Mediterranean region saw an 86% increase in that period. The European region rose by 47%, and Southeast Asia increased by 42%.

The African region saw a 40% drop in cases and a 50% fall in deaths. This good news comes from stronger vaccine coverage across African nations.

Measles is rising mostly where child mortality rates are lower. These areas benefit from better nutrition and consistent health care access. Still, infected children can suffer blindness, pneumonia, or encephalitis (brain swelling).

About 84% of children received their first measles dose in 2024. Only 76% received the required second dose, according to the WHO. The data show a slight improvement from 2023, with 2 million more immunizations. WHO guidance says 95% coverage with two doses is needed to stop transmission.

Over 30 million children lacked adequate measles protection in 2024. About 75% of these children live in the African and Eastern Mediterranean regions. Healthcare systems in these zones are more fragile and under-resourced. These gaps make it harder to maintain strong and reliable vaccine coverage.

Measles is the first disease that will return dangerously without full coverage. This warning comes from the WHO’s Immunization Agenda 2030 (IA 2030) midterm review. The report says ongoing outbreaks reveal weaknesses in global health systems. IA 2030 warns that current trends threaten efforts to eliminate measles by 2030.

In 2024, 59 countries experienced large or disruptive measles outbreaks. This number is nearly triple the number of outbreaks seen in 2021. The data also show the most outbreaks since the COVID-19 pandemic began. The Americas were the only region without at least one large outbreak in 2024.

Several countries have fought new outbreaks in 2025. Surveillance has strengthened, helping WHO and affected countries respond faster. Some nations have still managed to reach measles elimination. More than 760 laboratories in the Global Measles and Rubella Labratory Network (GMRLN) processed over 500,000 samples in 2024.

This total marks a 27% increase from 2023. Yet GMRLN has faced severe funding cuts. Immunization programs have also lost important financial support. These losses could worsen protection gaps and trigger more outbreaks.

How Can the World Achieve Measles Elimination?

More funding must support countries battling outbreaks and strengthen their partners. Increased investment is needed to close immunity gaps worldwide. Stronger commitments can help move the world toward measles elimination.

IA 2030’s goal to eliminate measles still needs major progress. By the end of 2024, only 42% of countries had eliminated measles. That total is only three more countries than before the pandemic.

Two of these nations are the first in the African region to be measles-free. The global total has now reached 96 measles-free countries. The Americas regained their measles-free status in 2024. However, that regional status was lost again in November 2025.

Measles continues returning, even in privileged countries that eliminated it. The main reason is national vaccine coverage falling below 95%. Small communities with lower vaccination rates can still fuel large outbreaks. These outbreaks then threaten safety across entire countries.

Political leaders must ensure children receive two full vaccine doses. They must also maintain strong surveillance to detect outbreaks quickly. Fast action helps eliminate new clusters before they spread widely. Strong commitment is essential to achieving global measles elimination.

Conclusion

Measles remains a major global threat despite years of strong progress. Rising outbreaks show how fragile protection becomes when vaccination rates drop. Stronger coverage and faster surveillance are essential to reach global elimination.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

A man joined his wife and children for a camping trip in summer 2024. The airline pilot and his family ate a late dinner at 10 p.m. They enjoyed beef steaks, even though the family usually consumed chicken. The night seemed normal until early morning.

The man woke at 2 a.m. with sudden and severe stomach pain. He writhed in bed while vomiting and having diarrhea. A few hours later, he felt better and slept through the night. He and his wife considered seeking medical advice but did not understand what happened.

Two weeks later, the man was back home in New Jersey. He and his wife attended a barbecue that afternoon. The man ate a hamburger at 3 p.m. and later mowed the lawn with no issues. His symptoms began at 7:20 p.m., and by 7:37 p.m., his son had called emergency services, but the man died three hours later.

His autopsy was inconclusive, but his wife sought definitive answers. She contacted her friend, Dr. Aaron McFeely, who reviewed the report and contacted Virginia researchers. Blood tests confirmed that the man had alpha-gal syndrome from a lone star tick bite, marking the first confirmed fatal transmission of this allergy. Researchers say this case shows why broader awareness of alpha-gal risks is urgently needed.

Why Does Alpha-Gal Trigger Allergic Reactions?

Allergist Thomas Platts-Mills urged broader awareness about alpha-gal risks. He said people in heavily populated tick regions should understand these dangers. He also warned that severe stomach pain hours after eating red meat requires urgent evaluation. People should confirm they have no alpha-gal allergies.

Alpha-gal is a common sugar that lives in cell membranes. However, alpha-gal does not naturally exist in human bodies. Tick bites can inject alpha-gal directly into the bloodstream. Human immune systems then create strong anti–alpha-gal antibodies.

These antibodies can trigger allergic reactions after eating alpha-gal again. Common sources include beef, lamb, pork, milk, and cheese. Symptoms include sneezing, runny nose, headaches, or faint-headedness. Severe symptoms include swelling, stomach pain, vomiting, and diarrhea.

Researchers have warned about alpha-gal syndrome for many months. Many suspected immune system overreactions could cause deadly responses. This recent case confirms those fears. The confirmation only happened because his wife pushed for answers.

Triptase levels in the man’s blood reached 2,000 nanograms per milliliter. Triptase helps measure severe anaphylactic shock in medical settings. This level is one of the highest ever recorded in fatal anaphylaxis. It highlighted the severity of his reaction.

What Do Researchers Want Readers to Know?

The couple initially thought small ankle bites were from chigger mites. These tiny insects are easy to confuse with young ticks. They live in warm weather near water, grass, and wooded areas. They also latch onto clothing and bite through skin.

These habits overlap with ticks, making confusion very common. Immature ticks are extremely small and hard to identify. The lone star tick is the main vector for alpha-gal syndrome. Its habitat range is expanding across new regions.

Growing deer populations help these ticks spread into northern states. Climate change supports the ticks by allowing survival in extreme temperatures. This lets the insects expand even farther. Other ticks in Australia, Europe, and Asia can also cause similar allergies.

Researchers say the most important message is very simple. Any stomach pain three to five hours after eating red meat needs urgent attention. They also note that isolated stomach pain can signal an allergic reaction. Tick bites should be checked if they itch longer than one week.

Chigger bites can still increase sensitivity to mammal meat. People should keep this overlap in mind. Many cases will remain mild or moderate. A responsive diet should help most people manage their symptoms.

Conclusion

This case confirms that alpha-gal syndrome can cause deadly reactions. Researchers warn that stomach pain after eating red meat should prompt urgent attention. They stress that growing tick populations make early awareness more important than ever.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Large gatherings in crowds may be contributing to a growing health challenge that threatens millions. Antimicrobial resistance (AMR) is an escalating global threat that makes deadly diseases harder to treat. Knowing how to mitigate this risk is crucial, as the danger posed by AMR is projected to increase in coming decades.

Recent research published in Nature Water demonstrated how large crowds help infect nearby wastewater systems with antibiotic resistance genes (ARGs). The findings contribute to a growing recognition of wastewater as a valuable disease surveillance tool. They also further highlight how large groups of people create pathogenic risk. Offsetting the increasing AMR of dangerous bacterial strains remains a top health priority.

What Were the Key Findings About Large Gatherings and AMR?

The study found ARGs in wastewater that boost resistance to two beta-lactam antibiotics. Both metallo-beta-lactamase (MBL) and extended-spectrum beta-lactamase (ESBL) appeared in collected samples. These findings explained antibiotic-resistant bacterial colonies researchers found in sewage after large gatherings.

No resistant colonies showed up in wastewater from a control plant that did not have mass gatherings nearby. The stark contrast provides clear evidence for how mass gatherings help AMR strains spread.

The study’s authors recommend that their discovery serves as a basis for future wastewater monitoring efforts. They also suggest that untreated sewage and poor quality wastewater infrastructure could increase the risk of AMR. Further research could use molecular analysis to more closely monitor the cultivation of bacteria with ARGs. Such investigations could lead to better prevention and awareness of AMR threats.

How Did the Study Show Large Gatherings Increase AMR?

Large gatherings after the COVID-19 pandemic provided a suitable opportunity see how they spread ARGs. The study documented sewage samples collected from plants that get untreated wastewater from large gatherings. Researchers also collected samples from locations in the nearby community. As a control, they also gathered samples from a plant that processed no wastewater from crowded events.

Metagenomic analysis allowed researchers to identity the prevalence of ARGs. The study also pinpointed a specific beta-lactamase gene that appeared during large gatherings. These findings strongly suggest that crowds spread ARGs through communities.

The study used gatherings observing Hajj and Umrah as part of Ramadan in Saudi Arabia. The Hajj pilgrimage gathers millions of religious observers to the cities of Mecca and Medina. The pilgrims all make their journeys over the same period of about a week. Researchers drew samples from Hajj pilgrimages during July 2020, 2021, and 2022. Umrah yielded samples collected during Ramadan in 2021 and 2022.

Researchers compared these samples to baseline data from 2017-2019 prior to the COVID-19 pandemic. By analyzing 649 metagenomes derived from 96 countries, they compared the abundance of ARGs in wastewater. As a result, the study could derive clear conclusions about the influence of mass gatherings on AMR resistance in communities.

Conclusion

A recent study shows how mass gatherings increase the potential for AMR to spread. Large crowds help introduce antimicrobial resistance genes (ARGs) to nearby wastewater systems. The findings could lead to better prevention and monitoring strategies for future outbreaks of AMR strains.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pixabay.

If one wanted to learn how to best kill bacteria, phages would be the first warriors to study. Phages and bacteria have fought an endless, microscopic war for billions of years. Their battle strategies may be the key to beating back bacterial strains with antimicrobial resistance (AMR).

AMR is a significant and worsening threat to public health. Millions of lives are jeopardized each year the crisis persists. Urgent intervention from governments and medical professionals can prevent tens of millions of deaths in coming decades.

Recent research published in Cell identified a unique strategy bacteria use to defend against phage attacks, called Kiwa. The study also revealed two strategies phages use to overcome Kiwa. These tactics could inform new therapies to combat bacterial strains with AMR.

How Do the Phage and Bacteria Combat Strategies Work?

Researchers pinpointed how bacteria’s Kiwa strategy responds to phage attack. Kiwa sits within bacterial cell membranes and sounds an alarm when it detects hostile phages. The study hypothesizes that Kiwa reacts when a phage grabs onto a cell to insert its DNA. Kiwa stops the phage from creating DNA building blocks that make new phages.

Meanwhile, phages can mutate the proteins that latch them onto bacterial cells. This shift makes them invisible to the Kiwa’s sensors. Phages can also generate mutations that prevent Kiwa from stopping DNA injection. The process isn’t fully understood, but it does allow phage viruses to reproduce after Kiwa activates.

Bacteria have many other protection mechanisms besides Kiwa. Further study can provide even more insight into possible therapies that target them. Eventually, the unique defenses of different strains can be identified and overcome on a case-specific basis.

What Limitations and Further Research Opportunities Did the Study Note?

The study noted a few key limitations of its findings. Both the molecules that trigger Kiwa and its activation method itself remain unknown. Future research needs to directly observe the process to gain a better understanding of Kiwa. It is also unclear exactly how Kiwa stops phages from replicating their DNA. Concrete data on these questions could shape more precise treatments for AMR strains.

The researchers of this study created the phage collection project as a basis for further exploration. The growing database is collecting information about phages in different regions. Observing the phages that defeat AMR bacteria could serve as a blueprint for future medicines. The catalog already includes over 600 phage entries and counting.

Conclusion

A recent study revealed strategies that phages and bacteria use against one another in an ancient war. Researchers found a unique bacterial defense against phages, called Kiwa. This finding, in addition to discoveries about phages’ own tactics, could shape new treatments for AMR bacterial strains.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

The Justinian Plague was the first pandemic in world history, spanning 541-750 CE. The previously unidentified pathogen unleashed massive destruction on the Byzantine Empire, brining tens of millions to their graves. Among historians, debates surrounding the plague’s origins have been marred in controversy. Now, the age-old question can finally be put to rest.

Researchers at the University of South Florida and Florida Atlantic University made a groundbreaking discovery. Along with Indian and Australian colleagues, they recovered Yersinia Pestis microbes from Jerash, Jordan. This city sits near the location historians have marked as the plague’s epicenter. Thus, publications from USF and FAU now claim Y. Pestis caused the world’s first pandemic.

What Were the Researchers’ Key Findings about Plague?

The new findings provide the first concrete evidence of the pathogen behind the Justinian Plague. The pathogen broke out in the Eastern Mediterranean over 1,500 years ago. Since then, historians have relied on written accounts to speculate its origins. Now, definitive genetic evidence proves that Y. Pestis was the primary driver of the ancient pandemic.

Prior research identified Y. Pestis in small villages of Western Europe. However, this finding is the first to locate the pathogen within the Byzantine Empire itself. Rooms for burial beneath what was once a Roman hippodrome–a horse racing arena–held the evidence. Teeth from human remains in the underground chambers held genetic traces of Y. Pestis.

Researchers hypothesize a rapid and deadly outbreak of plague caused these deaths. Recovered strains of Y. Pestis from the site were almost perfect matches with each other.

A related study led by the same universities shows this was not a one-off incident. Analysis of hundreds of pathogenic genomes shows the bacteria was already in circulation. After thousands of years of infections, an especially hard outbreak hit the Byzantine Empire.

The companion study also clarified that plague outbreaks do not share one common ancestral strain. Rather, different variants of Y. Pestis emerge in distinct time periods and locations throughout history. It is easy to think of pandemics as one-time major events. Yet, this research encourages a more nuanced perspective based on human activity and dynamic environmental factors.

How Did Researchers Derive New Conclusions about Plague?

Researchers collected material from the Jerash site. Then, they used genetic sequencing to identify specific pathogens. Results showed the prevalence of Y. Pestis among the nine recovered tooth samples.

Comparison of the genetic material with other Y. Pestis genomes showed their variety and wide spread. Future research will see investigations in Venice, Italy, and the Lazaretto Vecchio. The latter served as a quarantine island and holds a notable burial site. USF holds over 1,200 from this location.

Based on archaeological and historical evidence, researchers identified why Jerash was a hub for plague. “[Its] civic infrastructure–including aqueducts, baths, granaries, and amphitheaters–facilitated not only the flow of goods and people but also, inadvertently, pathogens,” the authors wrote. Cities like Jerash were communal hubs of the ancient world, and so disease easily spread in their crowded, dirty living conditions.

The study also noted how the burial site at Jerash clarified ancient public responses to outbreaks. Officials used architecture designed for entertainment to bury the rapidly accumulating dead. This improvisational tactic reflects how plague overwhelmed their infrastructure and medicinal capabilities.

Conclusion

Recent research revealed genetic evidence of pathogen behind the Justinian Plague. Yersinia Pestis DNA lingered in a mass grave located in Jerash, Jordan. The finding provides genetic proof of plague in the Byzantine Empire, while providing new insights into the disease.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.